Cleared Abbreviated

K230684 - RadiForce MX217 (FDA 510(k) Clearance)

Class II Radiology device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2023
Decision
60d
Days
Class 2
Risk

K230684 is an FDA 510(k) clearance for the RadiForce MX217. Classified as Display, Diagnostic Radiology (product code PGY), Class II - Special Controls.

Submitted by Eizo Corporation (Hakusan, JP). The FDA issued a Cleared decision on May 12, 2023 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Eizo Corporation devices

Submission Details

510(k) Number K230684 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 13, 2023
Decision Date May 12, 2023
Days to Decision 60 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 107d · This submission: 60d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code PGY Display, Diagnostic Radiology
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
Definition The Device Is Intended For Use In Displaying Radiological Images For Review, Analysis, And Diagnosis By Trained Medical Practitioners.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - PGY Display, Diagnostic Radiology

All 133
Devices cleared under the same product code (PGY) and FDA review panel - the closest regulatory comparables to K230684.
LCD Monitor (CL1902A, CL2103F)
K252780 · Shenzhen Beacon Display Technology Co., Ltd. · Dec 2025
LCD Monitor (C1216W, C822W, C821W)
K253242 · Shenzhen Beacon Display Technology Co., Ltd. · Oct 2025
RadiForce GX570
K252030 · Eizo Corporation · Aug 2025
RadiForce RX570
K243221 · Eizo Corporation · Nov 2024
LCD Monitors C310S, G310S, C316S, G316S, C616W
K243031 · Shenzhen Beacon Display Technology Co., Ltd. · Oct 2024
Coronis OneLook
K242008 · Barco N.V. · Aug 2024